AS OF NOVEMBER 2021, 30% of the US adult population is not fully vaccinated against COVID-19.1 Despite hopes earlier this year that vaccination rates would be higher at this point in the pandemic, the numbers are not as high as anticipated.

Health care, government, and life science organizations had a sharp learning curve to determine deployment strategies that ensured supply was accessible and equitable, in addition to assuring consumer confidence that the vaccines are effective and safe. Consumer sentiment around vaccines has shifted and continues to shift as the pandemic evolves. It has been almost a year since the first COVID-19 vaccine became available. What have we learned about consumer perspectives on vaccines that can be applied going forward to vaccination in general?